Abstract: Embodiments may generally take the form of a degradable composite structure and a method for controlling the rate of degradation of a degradable composite structure. An example embodiment may take the form of a degradable polymer matrix composite (PMC) including a matrix having: a degradable polymer, a fiber reinforcement, and particulate fillers. The fiber loading is between approximately 10% to 70% by weight and the particulate loading is between approximately 5% to 60%.

Abstract: Embodiments may generally take the form of a degradable composite structure and a method for controlling the rate of degradation of a degradable composite structure. An example embodiment may take the form of a degradable polymer matrix composite (PMC) including a matrix having: a degradable polymer, a fiber reinforcement, and particulate fillers. The fiber loading is between approximately 10% to 70% by weight and the particulate loading is between approximately 5% to 60%.

Abstract: Apparatus and methods for measuring confining pressure, axial strain and radial strain of zonal isolation materials are described. This information is useful for evaluating these materials and predicting seal performance and potential failures of these materials.

Abstract: Novel pyridine-2-carboxamide derivatives of formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are effective as glucokinase activating agents. Pharmaceutical compositions and methods of treatment are also included.

Abstract: Novel pyridine-2-carboxamide derivatives of formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are effective as glucokinase activating agents. Pharmaceutical compositions and methods of treatment are also included.

Abstract: Apparatus and methods for measuring confining pressure, axial strain and radial strain of zonal isolation materials are described. This information is useful for evaluating these materials and predicting seal performance and potential failures of these materials.

Abstract: Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Abstract: Methods and devices for mixing a first fluid with a second fluid downhole include a chamber having a first end, a second end and an opening for fluid to flow there through. A top surface of a perforated piston is capable of contacting the second end and a top surface of a piston is capable of contacting a bottom surface of the perforated piston. The perforated piston is located at a first position within the chamber based upon characteristics of a first fluid. A first fluid delivery system supplies the first fluid and a second fluid delivery system supplies a second fluid to the chamber, wherein the second fluid is at a pressure that moves the piston approximate to the first end. An actuating device applies a force against the bottom surface of the piston to inject the fluids through channels of the perforated piston to produce spray droplets.

Abstract: The isolation of selected regions downhole may be achieved using methods that include emplacing a polymerizable material within a wellbore, wherein the polymerizable material contains a polymerizable component and a latent curing agent; initiating polymerization of the polymerizable material; and forming a seal within the wellbore. Permanent or semi-permanent downhole seals may also be prepared using methods that include emplacing a section of pipe having a surrounding membrane into an interval of a wellbore, wherein the surrounding membrane contains a polymerizable material, and deploying the membrane downhole to form a seal.

Abstract: Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Abstract: Methods and devices for mixing a first fluid with a second fluid downhole include a chamber having a first end, a second end and an opening for fluid to flow there through. A top surface of a perforated piston is capable of contacting the second end and a top surface of a piston is capable of contacting a bottom surface of the perforated piston. The perforated piston is located at a first position within the chamber based upon characteristics of a first fluid. A first fluid delivery system supplies the first fluid and a second fluid delivery system supplies a second fluid to the chamber, wherein the second fluid is at a pressure that moves the piston approximate to the first end. An actuating device applies a force against the bottom surface of the piston to inject the fluids through channels of the perforated piston to produce spray droplets.

Abstract: Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Abstract: Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.